The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Biological effects in normal cells exposed to FLASH dose rate protons
Open accessAbstract
Background: Radiotherapy outcomes are limited by toxicity in the healthy tissues surrounding the irradiated tumor. Recent pre-clinical studies have shown that irradiations with electrons or photons delivered at so called FLASH dose rates (i.e. >40 Gy/s) dramatically reduce adverse side effects in the normal tissues while being equally efficient for tumor control as irradiations at conventional dose rates (3-5 cGy/s). In the case of protons however, FLASH effects have not been investigated partially because of the limited availability of facilities that can achieve such high dose rates. Methods: Using a novel irradiation platform, we measured acute and long-term biological effects in normal human lung fibroblasts (IMR90) exposed to therapeutically relevant doses of 4.5 MeV protons (LET =10 keV/μm) delivered at dose rates spanning four orders of magnitude. Endpoints included clonogenic cell survival, γH2AX foci formation, induction of premature senescence (β-gal), and the expression of the pro-inflammatory marker TGFß. Results: Proton dose rate had no influence on the cell survival, but for the highest dose rate used (i.e. 1000 Gy/s) foci formation saturated beyond 10 Gy. In the progeny of irradiated cells, an increase in dose (20 Gy vs. 10 Gy) and dose rate (1000 Gy/s vs. 0.05 Gy/s) positively affected the number of senescence cells and the expression of TGFß1. Conclusions: In normal lung fibroblasts proton dose rate had little impact on acute effects, but significantly influenced the expression of long-term biological responses in vitro. Compared to conventional dose rates, protons delivered at FLASH dose rates mitigated such delayed detrimental effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ACTION OF X-RAYS ON MAMMALIAN CELLS
Puck, T. T., & Marcus, P. I. (1956) · The Journal of Experimental Medicine · doi:10.1084/jem.103.5.653 · Cited by 1,696 · cited 1×
“05, 100 or 1000 Gy/s, the cells were trypsinized and seeded in 60-mm dishes at numbers that resulted in ~ 100 clonogenic cells per dish (21).”
BackgroundIonizing radiation-induced metabolic oxidative stress and prolonged cell injury
Azzam, E. I., Jay-Gerin, J.-P., & Pain, D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2011.12.012 · Cited by 1,553
Favaudon, V., Caplier, L., Monceau, V., Pouzoulet, F., Sayarath, M., Fouillade, C., Poupon, M.-F., Brito, I., Hupé, P., Bourhis, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008973 · Cited by 1,476
Role of oxidative stress and DNA damage in human carcinogenesis
Kryston, T. B., Georgiev, A. B., Pissis, P., & Georgakilas, A. G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2010.12.016 · Cited by 930
Paganetti, H. (2014) · Physics in Medicine and Biology · doi:10.1088/0031-9155/59/22/r419 · Cited by 915
The log transformation is special
Keene, O. N. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140810 · Cited by 498
Recent Developments in Radiotherapy
Citrin, D. E. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1608986 · Cited by 488
Montay-Gruel, P., Bouchet, A., Jaccard, M., Patin, D., Serduc, R., Aim, W., Petersson, K., Petit, B., Bailat, C., Bourhis, J., et al. (2018) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2018.08.016 · Cited by 405
An evidence based review of proton beam therapy: The report of ASTRO’s emerging technology committee
Allen, A. M., Pawlicki, T., Dong, L., Fourkal, E., Buyyounouski, M., Cengel, K., Plastaras, J., Bucci, M. K., Yock, T. I., Bonilla, L., et al. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.02.001 · Cited by 236
Role of Type II Pneumocyte Senescence in Radiation-Induced Lung Fibrosis
Citrin, D. E., Shankavaram, U., Horton, J. A., Shield, W., Zhao, S., Asano, H., White, A., Sowers, A., Thetford, A., & Chung, E. J. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt212 · Cited by 174
Buonanno, M., de Toledo, S. M., Pain, D., & Azzam, E. I. (2011) · Radiation Research · doi:10.1667/rr2461.1 · Cited by 158
Self-citationPan, H. Y., Jiang, J., Hoffman, K. E., Tang, C. Z., Choi, S. L., Nguyen, Q., Frank, S. J., Anscher, M. S., Shih, Y. T., & Smith, B. D. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.5371 · Cited by 114
Zlobinskaya, O., Siebenwirth, C., Greubel, C., Hable, V., Hertenberger, R., Humble, N., Reinhardt, S. C. M., Michalski, D., Röper, B., Multhoff, G., et al. (2014) · Radiation Research · doi:10.1667/rr13464.1 · Cited by 113
Schmid, T. E., Dollinger, G., Beisker, W., Hable, V., Greubel, C., Auer, S., Mittag, A., Tárnok, A., Friedl, A. A., Molls, M., et al. (2010) · International Journal of Radiation Biology · doi:10.3109/09553001003734543 · Cited by 93
Inactivation of Synchronized Chinese Hamster V79 Cells with Charged-Particle Track Segments
Bird, R. P., Rohrig, N., Colvett, R. D., Geard, C. R., & Marino, S. A. (1980) · Radiation Research · doi:10.2307/3575379 · Cited by 88
Adapting the γ-H2AX Assay for Automated Processing in Human Lymphocytes. 1. Technological Aspects
Turner, H. C., Brenner, D. J., Chen, Y., Bertucci, A., Zhang, J., Wang, H., Lyulko, O. V., Xu, Y., Shuryak, I., Schaefer, J., et al. (2010) · Radiation Research · doi:10.1667/rr2125.1 · Cited by 84
Self-citationSchmid, T. E., Dollinger, G., Hable, V., Greubel, C., Zlobinskaya, O., Michalski, D., Molls, M., & Röper, B. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2010.03.010 · Cited by 82
Schmid, T. E., Dollinger, G., Hable, V., Greubel, C., Zlobinskaya, O., Michalski, D., Auer, S., Friedl, A. A., Schmid, E. W., Molls, M., et al. (2011) · Radiation Research · doi:10.1667/rr2465.1 · Cited by 51
Towards ion beam therapy based on laser plasma accelerators
Karsch, L., Beyreuther, E., Enghardt, W., Gotz, M. D., Masood, U., Schramm, U., Zeil, K., & Pawelke, J. (2017) · Acta Oncologica · doi:10.1080/0284186x.2017.1355111 · Cited by 51
Zlobinskaya, O., Dollinger, G., Michalski, D., Hable, V., Greubel, C., Du, G., Multhoff, G., Röper, B., Molls, M., & Schmid, T. E. (2012) · Radiation and Environmental Biophysics · doi:10.1007/s00411-011-0398-1 · Cited by 44
Cited by
Clinical translation of FLASH radiotherapy: Why and how?
Bourhis, J., Montay-Gruel, P., Gonçalves Jorge, P., Bailat, C., Petit, B., Ollivier, J., Jeanneret-Sozzi, W., Ozsahin, M., Bochud, F., Moeckli, R., et al. (2019) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2019.04.008 · Cited by 474
Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?
Wilson, J. D., Hammond, E. M., Higgins, G. S., & Petersson, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01563 · Cited by 473
Towards clinical translation of FLASH radiotherapy
Vozenin, M.-C., Bourhis, J., & Durante, M. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00697-z · Cited by 363
Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review
Esplen, N., Mendonca, M. S., & Bazalova-Carter, M. (2020) · Physics in Medicine & Biology · doi:10.1088/1361-6560/abaa28 · Cited by 270
FLASH Radiotherapy: Current Knowledge and Future Insights Using Proton-Beam Therapy
Hughes, J. R., & Parsons, J. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186492 · Cited by 267
Metadata
- Authors
- Buonanno, M., Grilj, V., & Brenner, D. J.
- Venue
- Radiotherapy and Oncology
- Publisher
- Elsevier BV
- Published
- 2019-10
- Volume
- 139
- Pages
- 51-55
- ISSN
- 0167-8140 (ISSN-L)
- OpenAlex
- W2918729233
- Cited by
- 306
- References
- 20
- FWCI
- 24.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.